135 related articles for article (PubMed ID: 37379111)
1. [Bilateral uveitis associated with protein kinase inhibitor-based treatment of skin melanoma (case study)].
Udovichenko EV; Danilova LP; Sorokin EL; Fil AA
Vestn Oftalmol; 2023; 139(3):69-75. PubMed ID: 37379111
[TBL] [Abstract][Full Text] [Related]
2. Uveitis in patients with late-stage cutaneous melanoma treated with vemurafenib.
Guedj M; Quéant A; Funck-Brentano E; Kramkimel N; Lellouch J; Monnet D; Longvert C; Gantzer A; Brézin AP
JAMA Ophthalmol; 2014 Dec; 132(12):1421-5. PubMed ID: 25125216
[TBL] [Abstract][Full Text] [Related]
3. Sarcoid-like Granulomatous Intraocular Inflammation Caused by Vemurafenib Treatment for Metastatic Melanoma.
Eser Öztürk H; Süllü Y
Turk J Ophthalmol; 2020 Mar; 50(1):50-52. PubMed ID: 32167264
[TBL] [Abstract][Full Text] [Related]
4. A Rare Cause of Uveitis: Vemurafenib.
Sızmaz S; Görkemli N; Esen E; Demircan N
Turk J Ophthalmol; 2018 Dec; 48(6):323-325. PubMed ID: 30605942
[TBL] [Abstract][Full Text] [Related]
5. [Ocular toxicity of targeted therapies with MEK inhibitors and BRAF inhibitors in the treatment of metastatic cutaneous melanoma].
Fauviaux E; Promelle V; Boucenna V; Jany B; Errera MH; Delbarre M; Boucenna W
J Fr Ophtalmol; 2022 Jun; 45(6):612-618. PubMed ID: 35501194
[TBL] [Abstract][Full Text] [Related]
6. Severe pan-uveitis in a patient treated with vemurafenib for metastatic melanoma.
Wolf SE; Meenken C; Moll AC; Haanen JB; van der Heijden MS
BMC Cancer; 2013 Dec; 13():561. PubMed ID: 24289205
[TBL] [Abstract][Full Text] [Related]
7. Uveitic macular oedema after treatment with vemurafenib.
Fonollosa A; Mesquida M; Adan A
Acta Ophthalmol; 2015 Dec; 93(8):e686-7. PubMed ID: 25683228
[No Abstract] [Full Text] [Related]
8. Ocular toxicity in BRAF mutant cutaneous melanoma patients treated with vemurafenib.
Choe CH; McArthur GA; Caro I; Kempen JH; Amaravadi RK
Am J Ophthalmol; 2014 Oct; 158(4):831-837.e2. PubMed ID: 25036880
[TBL] [Abstract][Full Text] [Related]
9. Fluocinolone acetonide intravitreal implant (Retisert
Leinonen S; Immonen I; Kotaniemi K
Acta Ophthalmol; 2018 Sep; 96(6):648-651. PubMed ID: 29655222
[TBL] [Abstract][Full Text] [Related]
10. Acute bilateral uveitis and right macular edema induced by a single infusion of zoledronic acid for the treatment of postmenopausal osteoporosis as a substitution for oral alendronate: a case report.
Tian Y; Wang R; Liu L; Ma C; Lu Q; Yin F
BMC Musculoskelet Disord; 2016 Feb; 17():72. PubMed ID: 26867651
[TBL] [Abstract][Full Text] [Related]
11. Clinical and optical coherence tomographic findings and outcome of treatment in patients with presumed tuberculous uveitis.
Al-Mezaine HS; Al-Muammar A; Kangave D; Abu El-Asrar AM
Int Ophthalmol; 2008 Dec; 28(6):413-23. PubMed ID: 18034214
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal Steroid Treatment for Uveitis Associated with Dabrafenib and Trametinib for Metastatic Cutaneous Melanoma.
Woltsche N; Kruger MA; Weger M; Wolf IH; Seidel G
Ocul Immunol Inflamm; 2021 Jul; 29(5):845-847. PubMed ID: 31906779
[No Abstract] [Full Text] [Related]
13. Medical Therapy of Uveitic Macular Edema: Biologic Agents.
Radosavljevic A; Agarwal M; Bodaghi B; Smith JR; Zierhut M
Ocul Immunol Inflamm; 2020 Nov; 28(8):1239-1250. PubMed ID: 32058830
[No Abstract] [Full Text] [Related]
14. Bilateral effect of unilateral ranibizumab in patients with uveitis-related macular edema.
Acharya NR; Sittivarakul W; Qian Y; Hong KC; Lee SM
Retina; 2011 Oct; 31(9):1871-6. PubMed ID: 21716165
[TBL] [Abstract][Full Text] [Related]
15. Bilateral uveitis and macular edema induced by Nivolumab: a case report.
Theillac C; Straub M; Breton AL; Thomas L; Dalle S
BMC Ophthalmol; 2017 Dec; 17(1):227. PubMed ID: 29195497
[TBL] [Abstract][Full Text] [Related]
16. [Bilateral cystoid macular edema in an older female patient with tubulointerstitial nephritis and uveitis (TINU syndrome)].
Welzl-Hinterkörner E; Thölen A
Klin Monbl Augenheilkd; 2000 Feb; 216(2):116-7. PubMed ID: 10730229
[TBL] [Abstract][Full Text] [Related]
17. Bilateral panuveitis in a patient on vemurafenib BRAF inhibitor therapy for stage IV melanoma.
Agemy SA; Mehta AN; Pachydaki SI; Tewari A
Eur J Ophthalmol; 2014; 24(4):629-32. PubMed ID: 24474376
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal ketorolac for chronic uveitis and macular edema: a pilot study.
Kim SJ; Doherty TJ; Cherney EF
Arch Ophthalmol; 2012 Apr; 130(4):456-60. PubMed ID: 22491916
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Vemurafenib Treatment in 43 Metastatic Melanoma Patients with BRAF Mutation. Single-Institute Retrospective Analysis, Early Real-Life Survival Data.
Czirbesz K; Gorka E; Balatoni T; Pánczél G; Melegh K; Kovács P; Gézsi A; Liszkay G
Pathol Oncol Res; 2019 Jan; 25(1):45-50. PubMed ID: 28963614
[TBL] [Abstract][Full Text] [Related]
20. [Dexamethason implant in the treatment of macular edema in retinal vein occlusion and intraocular inflammatory disease].
Brunner M; Haueter I; Valmaggia C
Klin Monbl Augenheilkd; 2013 Apr; 230(4):396-400. PubMed ID: 23629790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
